zolmitriptan


Also found in: Medical, Acronyms, Wikipedia.

zol·mi·trip·tan

 (zŏl′mĭ-trĭp′tn)
n.
A drug that acts as a serotonin receptor agonist and is used to treat migraine headaches.

[(a)zol(e) + (a)mi(no) + -triptan, triptan suffix; see triptan.]
Translations

zolmitriptan

n zolmitriptán m
References in periodicals archive ?
Major Finding: The menstrual migraine recurrence rate 48 hours after treatment with frovatriptan was 15%, significantly less than the collective 26% rate after treatment with rizatriptan, zolmitriptan, or almotriptan.
Oral zolmitriptan is effective in the acute treatment of cluster headache.
Zolmitriptan nasal spray has recently been approved in the Netherlands, Denmark and Germany by their national licensing authorities for the acute treatment of cluster headache, but is not yet licensed in the United Kingdom.
In terms of pain relief, 55% of patients who received telcagepant 300 mg and 56% of those who received zolmitriptan reported 2-hour pain relief, defined as reduction in pain to mild or no pain, and 27% of the telcagepant patients and 31% of the zolmitriptan patients reported being pain free at 2 hours.
Four triptans are registered for use in South Africa, namely sumatriptan (Imigran[R]), rizatriptan (Maxalt[R]), naratriptan (Naramig[R]) and zolmitriptan (Zomig[R]).
Recommended acute therapies for migraine attacks available in the United States NSAIDs * Aspirin * Ibuprofen * Naproxen sodium * Acetaminophen + aspirin + caffeine Opiates/barbiturate hypnotics * Intranasal butorphanol * Other opiates and butalbital-containing compounds may be considered for use as "rescue medications" Ergotamine and derivatives * DHE nasal spray * SC/IM/IV DHE * IV DHE and antiemetic Triptans * Almotriptan (tablets) * Eletriptan (tablets) * Frovatriptan (tablets) * Naratriptan (tablets) * Rizatriptan (tablets, orally disintegrating tablets) * Sumatriptan (tablets, nasal spray, subcutaneous injections, suppositories) * Zolmitriptan (tablets, nasal spray, orally disintegrating tablets) NSAIDs, nonsteroidal anti-inflammatory drugs; DHE, dihydroergotamine.
As these clinical study results demonstrate, zolmitriptan is the first oral triptan to provide rapid onset for patients who experience this unique, debilitating kind of headache.
The latest drugs are sumariptan, zolmitriptan and naratriptan which have the advantage of working when an attack is under way.
Variations of the drug are being developed including Zolmitriptan.
Jubilant Life Sciences has obtained Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Zolmitriptan Orally Disintegrating Tablets, 2.
Launch of five triptan reformulations will offset generic erosion of the triptan class: Multiple non-tablet triptan reformulations are expected to launch during the forecast period: Teva's Zecuity (sumatriptan transdermal patch), Avanir Pharmaceuticals/OptiNose's AVP-825 (sumatriptan intranasal powder), Applied Pharma Research/tesa Labtech's zolmitriptan oral dispersible film (ODF), IntelGenX/RedHill Biopharma's Rizaport (rizatriptan ODF) and Suda's SUD-001 (sumatriptan oral spray).
Triptans like Sumatriptan and Zolmitriptan are also available as nasal sprays whereas rizatriptan and zolmitriptan are available as tablets that dissolve in the mouth.